Andere talen Viking Therapeutics, Inc.

Aandelen

VKTX

US92686J1060

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 24-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
65,07 ^USD	+0,22%		-4,24%	+249,65%

24/04	Transcript : Viking Therapeutics, Inc., Q1 2024 Earnings Call, Apr 24, 2024
27/03	VIKING THERAPEUTICS, INC. : Oppenheimer geeft koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Viking Therapeutics Q1 Loss Widens; Shares Fall After Hours	24/04
6 Stocks Positioned to Soar as Investors Focus on MASH	22/04
Viking Therapeutics to Report Financial Results for First Quarter 2024 on April 24, 2024	17/04
Health Care Falls as Risk Aversion Weighs on Obesity Drug Makers -- Health Care Roundup	12/04
Health Care Down on Flight From Risk -- Health Care Roundup	02/04
Health Care Down as Obesity-Drug Optimism Fades -- Health Care Roundup	01/04
Health Care Climbs on Weight-Loss Drug Excitement -- Health Care Roundup	26/03
Sector Update: Health Care Stocks Rise Tuesday Afternoon	26/03
Sector Update: Health Care	26/03
Viking Therapeutics Share Rise After Reporting 'Positive Results' in Study of Potential Obesity Drug	26/03
Sector Update: Health Care Stocks Steady Premarket Tuesday	26/03
Sector Update: Health Care	26/03
Viking Therapeutics Reports 'Positive Results' in Study of Potential Obesity Drug; Shares Jump	26/03
PE firm Olympus to sell 9.8% stake in India's Aster DM Healthcare for up to $234.5 million, term sheet shows	26/03
Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Oral Tablet Formulation of Dual GLP-1/GIP Receptor Agonist VK2735	26/03
Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Oral Tablet Formulation of Dual GLP-1/GIP Receptor Agonist VK2735	26/03
Viking Therapeutics Announces $632.5 Million Public Offering Of Common Stock	13/03
Viking Therapeutics Raises $632.5 Million Via Common Stock Offering	04/03
Viking Therapeutics Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional Shares	04/03
Health Care Up on Strong Earnings -- Health Care Roundup	29/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Viking Therapeutics, Inc.

Aandelen

VKTX

US92686J1060

Andere talen

Filters